Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Description | DuoResp Spiromax 160micrograms/dose / 4.5micrograms/dose dry powder inhaler (Teva UK Ltd) |
| BNF code | 0302000K0BHAAAM |
| Virtual Medicinal Product | Budesonide 200micrograms/dose / Formoterol 6micrograms/dose dry powder inhaler |
| Name | DuoResp Spiromax 160micrograms/dose / 4.5micrograms/dose dry powder inhaler |
| Abbreviated name | DuoResp Spiromax 160microg/dose / 4.5microg/dose dry pdr inh |
| Supplier | Teva UK Ltd |
| Current licensing authority | Medicines - MHRA/EMA |
| EMA additional monitoring | ✗ |
| Parallel import | ✗ |
| Restrictions on availability | None |
| Licensed Route | |
|---|---|
| Licenced route | Inhalation |
| Actual Medicinal Product Packs | |
| DuoResp Spiromax 160micrograms/dose / 4.5micrograms/dose dry powder inhaler (Teva UK Ltd) 120 dose | |
dm+d data retrieved from TRUD: release NHSBSA_2.0.0_20250203000001, imported on 4th February 2025 at 03:53:58.